431 related articles for article (PubMed ID: 15489218)
1. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.
Pujol A; Ferrer I; Camps C; Metzger E; Hindelang C; Callizot N; Ruiz M; Pàmpols T; Giròs M; Mandel JL
Hum Mol Genet; 2004 Dec; 13(23):2997-3006. PubMed ID: 15489218
[TBL] [Abstract][Full Text] [Related]
2. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
3. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
4. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
[TBL] [Abstract][Full Text] [Related]
5. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.
Maier EM; Mayerhofer PU; Asheuer M; Köhler W; Rothe M; Muntau AC; Roscher AA; Holzinger A; Aubourg P; Berger J
Biochem Biophys Res Commun; 2008 Dec; 377(1):176-80. PubMed ID: 18834860
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.
Ferrer I; Kapfhammer JP; Hindelang C; Kemp S; Troffer-Charlier N; Broccoli V; Callyzot N; Mooyer P; Selhorst J; Vreken P; Wanders RJ; Mandel JL; Pujol A
Hum Mol Genet; 2005 Dec; 14(23):3565-77. PubMed ID: 16223892
[TBL] [Abstract][Full Text] [Related]
7. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.
Fourcade S; Savary S; Albet S; Gauthé D; Gondcaille C; Pineau T; Bellenger J; Bentejac M; Holzinger A; Berger J; Bugaut M
Eur J Biochem; 2001 Jun; 268(12):3490-500. PubMed ID: 11422379
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Weinhofer I; Forss-Petter S; Zigman M; Berger J
Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the adrenoleukodystrophy-related (ALDR, ABCD2) gene promoter: inductibility by retinoic acid and forskolin.
Pujol A; Troffer-Charlier N; Metzger E; Chimini G; Mandel JL
Genomics; 2000 Nov; 70(1):131-9. PubMed ID: 11087670
[TBL] [Abstract][Full Text] [Related]
10. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
[TBL] [Abstract][Full Text] [Related]
11. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
12. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
[TBL] [Abstract][Full Text] [Related]
13. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.
Pujol A; Hindelang C; Callizot N; Bartsch U; Schachner M; Mandel JL
Hum Mol Genet; 2002 Mar; 11(5):499-505. PubMed ID: 11875044
[TBL] [Abstract][Full Text] [Related]
14. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
[TBL] [Abstract][Full Text] [Related]
16. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
17. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
18. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J; Khan M; Singh I
Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
[TBL] [Abstract][Full Text] [Related]
20. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.
Fourcade S; Ruiz M; Camps C; Schlüter A; Houten SM; Mooyer PA; Pàmpols T; Dacremont G; Wanders RJ; Giròs M; Pujol A
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E211-21. PubMed ID: 18854420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
